CrownCast

🎥Crown Bioscience
  • 0.0 (0)
  • LIFE SCIENCES

CrownCast, Crown Bioscience's podcast aims to discuss the emerging trends, breakthroughs, and viewpoints in oncology drug discovery, and development.

  1. Mastering Radiopharmaceutical Development - Preclinical Model Selection for Clinical Success

    MAR 26 ·  VIDEO

    Mastering Radiopharmaceutical Development - Preclinical Model Selection for Clinical Success

    What if the next breakthrough in cancer treatment isn't a pill or infusion, but a precisely targeted radioactive payload that hunts down tumor cells like a guided missile? In this Smart Biotech Scientist Podcast episode, Dr. David Brühlmann speaks with Bryan Miller, Director of Scientific and Technical Operations at Crown Bioscience UK, about the radiopharmaceutical revolution transforming oncology. From theranostic approaches to advanced preclinical modeling, Miller shares insights on how this emerging therapeutic class is reshaping cancer treatment strategies.

    34 min
  2. Beyond Efficacy: Why DMPK and Toxicology Matter Earlier Than You Think

    MAR 19 ·  VIDEO

    Beyond Efficacy: Why DMPK and Toxicology Matter Earlier Than You Think

    When people hear Crown Bioscience, they often think of world-class in vivo oncology models - and for good reason. But behind every successful oncology program is something just as critical: understanding how a drug behaves in the body and whether it can do so safely. In this CrownCast episode, host Michelle Dawn Mooney sits down with Rekha Pal, Senior Director of Scientific Engagement, and Santi Suryani Chen, Director of Business Development at Crown Bioscience, to explore where DMPK and toxicology fit into the drug discovery picture and how getting them right can save programs from costly detours.

    19 min
  3. ADC Development Revolution - Leveraging Translational Models for Next-Generation Cancer Therapeutics

    FEB 25 ·  VIDEO

    ADC Development Revolution - Leveraging Translational Models for Next-Generation Cancer Therapeutics

    CrownCast

    25 min
  4. CrownCast - The Radiopharmaceutical Revolution Driving Precision in Treatment

    JAN 8 ·  VIDEO

    CrownCast - The Radiopharmaceutical Revolution Driving Precision in Treatment

    CrownCast

    26 min
  5. Transforming Cancer Drug Development in the UK: Perspectives and Breakthroughs

    11/11/2025 ·  VIDEO

    Transforming Cancer Drug Development in the UK: Perspectives and Breakthroughs

    Across the global oncology drug discovery landscape, the UK stands at the forefront. In this CrownCast episode, Rajendra Kumari, Executive Director of Integrated Solutions at Crown Bioscience, talks with Sarah Wagner, Senior Director of Business Development and Bryan Miller, Director of Scientific and Technical Operations about leveraging the UK’s vibrant ecosystem of cutting-edge technologies, strong collaborations, and a commitment to high ethical standards.

    25 min
  6. Harnessing the Power of High-quality Biospecimens

    10/30/2025 ·  VIDEO

    Harnessing the Power of High-quality Biospecimens

    As cancer research progresses rapidly, obtaining high-quality biospecimens has grown increasingly important for making significant breakthroughs. In this CrownCast episode, Rajendra Kumari, Executive Director of Integrated Solutions at Crown Bioscience, talks with Sadaf Malik, Senior Director, Head US Sales (Biobank and Biomarker) about how superior biospecimens can drive advancements in oncology by means of innovative biobanking.

    26 min
  7. The Future of Drug Development: How Organoids Are Leading the Charge

    08/05/2025 ·  VIDEO

    The Future of Drug Development: How Organoids Are Leading the Charge

    As the landscape of drug discovery evolves, breakthrough technologies like organoids are gaining traction for their potential to revolutionize how new treatments are developed. In this episode of CrownCast, Jonny McMichael, Vice President at Crown Bioscience, and Leo Price, a member of Crown Bioscience’s Scientific Advisory Board, shed light on organoids' growing role in drug development. With insights into their application, this commentary delves into a technology that offers a significant leap toward personalized medicine, ushering in a new era for the healthcare industry.

    33 min

  8. 06/27/2025 ·  VIDEO

    Navigating the Future of Preclinical Testing Post-FDA Animal Testing Mandate

    In the relentlessly evolving landscape of drug discovery, modern technologies and groundbreaking methods are going beyond animal testing to ensure a more human-centric, efficient, and improved approach in terms of reliability. It's a journey that promises a more efficient future for pharmaceutical companies and, ultimately, patients worldwide. Dive into the details with industry leader Professor Thomas Hartung, shedding light on how policy changes and innovative technologies are setting the stage for the future. What You'll Learn 00:15 — Cutting-Edge Advances in Non-Animal Testing 07:50 — Regulatory Shifts with the FDA Modernization Act 15:30 — The Role of AI in Drug Discovery 24:10 — Integrating New Approaches into Current Practices Main Points of Conversation: In a time when the complexities of drug development demand rapid, accurate solutions, the adoption of alternative methodologies is crucial. As regulatory bodies worldwide signal a shift away from animal testing, the opportunities for innovative technologies to provide human-relevant data are immense. Executives and decision-makers must understand these transformations to maintain competitive advantages and drive industry standards forward.

    25 min
See All (15)

About

CrownCast, Crown Bioscience's podcast aims to discuss the emerging trends, breakthroughs, and viewpoints in oncology drug discovery, and development.

Information

  • Creator
    🎥Crown Bioscience
  • Years Active
    2025 - 2026
  • Episodes
    15
  • Rating
    Clean
  • Copyright
    © 2025
  • Show Website
    CrownCast